🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 17 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/04/2004 20,76 21,00 19,80 20,82 +2,06% 5,78% 59.150
22/04/2004 19,80 21,00 19,80 20,40 +7,26% 6,06% 104.500
21/04/2004 19,14 19,50 18,66 19,02 +2,26% 4,39% 34.700
20/04/2004 20,10 20,16 18,42 18,60 -7,19% 8,66% 34.567
19/04/2004 19,08 20,04 18,66 20,04 +7,40% 7,23% 35.133
16/04/2004 18,78 19,14 18,30 18,66 +0,65% 4,47% 21.967
15/04/2004 19,62 19,68 18,48 18,54 -6,08% 6,12% 37.400
14/04/2004 19,56 20,22 18,60 19,74 +0,61% 8,28% 43.900
13/04/2004 20,94 21,00 19,56 19,62 -5,49% 6,88% 57.167
12/04/2004 21,30 21,30 20,40 20,76 +0,00% 4,23% 35.817
08/04/2004 21,30 21,54 20,40 20,76 -3,35% 5,35% 36.200
07/04/2004 21,36 21,72 20,40 21,48 +2,87% 6,18% 70.933
06/04/2004 20,64 21,60 19,92 20,88 +3,26% 8,14% 111.783
05/04/2004 20,64 20,70 19,62 20,22 +0,30% 5,23% 68.867
02/04/2004 21,36 21,36 19,38 20,16 -2,61% 9,27% 124.783
01/04/2004 19,26 22,44 19,14 20,70 +13,86% 17,13% 510.883
31/03/2004 18,72 18,78 17,46 18,18 -0,33% 7,05% 34.350
30/03/2004 17,28 18,48 17,22 18,24 +5,19% 7,29% 54.100
29/03/2004 17,40 18,00 16,86 17,34 +0,00% 6,55% 54.000
26/03/2004 18,06 18,12 17,34 17,34 -4,30% 4,32% 33.367
25/03/2004 17,58 18,18 17,16 18,12 +4,50% 5,80% 53.350
24/03/2004 17,88 18,48 17,16 17,34 -3,02% 7,38% 44.983
23/03/2004 17,76 18,72 17,40 17,88 +2,05% 7,43% 54.600
22/03/2004 19,20 19,20 17,52 17,52 -9,32% 8,75% 79.817
19/03/2004 19,86 20,46 19,32 19,32 -0,31% 5,74% 76.533
18/03/2004 19,50 19,80 18,78 19,38 +3,53% 5,23% 81.100
17/03/2004 17,40 18,72 17,40 18,72 +8,33% 7,59% 78.933
16/03/2004 18,18 18,30 16,20 17,28 -4,00% 11,55% 91.083
15/03/2004 18,78 19,08 17,88 18,00 -5,66% 6,39% 60.883
12/03/2004 18,66 19,80 18,66 19,08 +2,58% 6,11% 62.950